[The stimulating action of lipopolysaccharide and muramyl dipeptide on the activation of mononuclear cells in human peripheral blood by recombinant interleukin-2 in vitro]

Biull Eksp Biol Med. 1988 Dec;106(12):698-701.
[Article in Russian]

Abstract

Muramyl dipeptide (MDP) and lipopolysaccharide (LPS) were effective in augmentation of killer cells generation from human peripheral blood mononuclear cells (PBMC) in response to recombinant human interleukin-2 (IL-2). Pretreatment of PBMC with combination of LPS and MDP resulted in most significant their proliferation stimulated by IL-2. Thus our results show the enhancement of PBMC sensitivity to IL-2 by action of LPS, MDP and most of all by their combination in vitro.

MeSH terms

  • Acetylmuramyl-Alanyl-Isoglutamine / pharmacology*
  • Cell Division / drug effects
  • Cells, Cultured
  • Escherichia coli*
  • Female
  • Humans
  • Interleukin-2 / pharmacology*
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Lipopolysaccharides / pharmacology*
  • Lymphocyte Activation / drug effects*
  • Male
  • Recombinant Proteins / pharmacology

Substances

  • Interleukin-2
  • Lipopolysaccharides
  • Recombinant Proteins
  • Acetylmuramyl-Alanyl-Isoglutamine